Sandra Block, MD
Sleep Medicine · Williamsville, NYNPI 1205806627
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 71.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,344 and has fallen 96.6% since, to $46 in 2025.
Across 31 payments — averaging $64.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$1K
- Harmony Biosciences LLC$253
- Eisai Inc.$125
- Jazz Pharmaceuticals Inc.$93
- Avadel CNS Pharmaceuticals, LLC$63
- Fisher & Paykel Healthcare Inc$26
- plus $13 from 1 others
What the payments were for
- Travel & lodging$1,16358%
- Food & beverage$77439%
- Education$703%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 13 | $1,435 |
| Harmony Biosciences LLC | 9 | $253 |
| Eisai Inc. | 1 | $125 |
| Jazz Pharmaceuticals Inc. | 2 | $93 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $63 |
| Fisher & Paykel Healthcare Inc | 1 | $26 |
| GE HealthCare | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,008 in reported general payments places this provider in the 60th percentile of 81 sleep medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 28 | $4,103 |
| Ramelteon | 18 | $1,014 |
| Armodafinil | 13 | $512 |
| Ropinirole Hcl | 14 | $287 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 13 | $247 |
| Gabapentin | 15 | $165 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Williamsville
- Daniel RifkinWilliamsville$262
- David RapoportNew York$313K
- Ofer JacobowitzNew York$141K
- Qanta AhmedMineola$83K
- Andrew WestwoodNew York$82K
- Omar BurschtinNew York$71K
- Maha AhmadNew York$38K
- Daniel BaroneNew York$37K
- James ChmielE. Amherst$30K
- Vincent GrbachNew York$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.